Home › NCT07846371
Effect of a Dietary Supplement Versus Placebo on Serum PFAS Levels in Male Firefighters
RecruitingHealthy volunteers welcome
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study Evaluating a Dietary Supplement Supporting Natural Elimination Processes in Male Firefighters
Who can join
Ages 18 and older · Men · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Able to give written informed consent * Male firefighter with previous career exposure to PFAS * BMI between 18.5 and 35 kg/m² * Serum PFOS level ≥5 ng/mL at screening * Willing to consume the study product daily for the duration of the study Exclusion Criteria: * History of drug and/or alcohol abuse (\>15 standard drinks per week) * Food allergy, intolerance or dietary restriction that, in the opinion of the investigator, would preclude consumption of the study product * Blood donation within the past 3 months * Current smoker of \>20 cigarettes per day, or former smoker with a history of ≥20 cigarettes per day who quit within 6 months prior to Visit 1 * Any significant acute or chronic health condition that would prevent participation, pose a risk, or confound interpretation of results, including: diagnosed gastrointestinal disorders (irritable bowel syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, coeliac disease, or other chronic diarrhoeal disorders); uncontrolled medical conditions; history of chronic kidney or liver disease; chronic inflammatory or autoimmune disease; history of gastrointestinal surgery; hospitalisation within the past 3 months * Current or recent (past 12 weeks) use of medications affecting bile acid metabolism (e.g. bile acid sequestrants, fibrates) or antibiotics * Current or recent (past 4 weeks) use of supplements affecting gut microbiota (prebiotics, probiotics, postbiotics, fibres, synbiotics), detoxification pathways (milk thistle, N-acetylcysteine, glutathione) or bile acid metabolism (e.g. psyllium husk) * Current or recent (past 2 weeks) consumption of prohibited foods, including probiotic yoghurts * Considered by the investigator unlikely to comply with study requirements * Current participation in another clinical study, or insufficient time elapsed since a previous experimental study
About the study
This study is designed to evaluate the effect of a probiotic dietary supplement containing Streptococcus salivarius on serum PFAS levels in male firefighters with documented occupational PFAS exposure, following twice-daily use over a 12-week period.
What is being tested
- Streptococcus salivarius 46-SL1 (dietary supplement)
- Placebo (dietary supplement)
Sponsor: Cambiotics ApS · Participants: 70 · Started: Oct 8, 2026
Contact the study team
- Abigail O'Mahony, Operations Manager · Phone: +1 312 535-9440
- Stacey Boetto, Princpal Investigator, DNP, FNP-C · Phone: 312-535-9440
Official record on ClinicalTrials.gov — NCT07846371
Locations in the U.S.
| Illinois | Atlantia Clinical Trials, Chicago |
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.